Stefania Simou
European Medicines Agency(NL)
Publications by Year
Research Areas
Inflammatory Myopathies and Dermatomyositis, Health, Medicine and Society, Hermeneutics and Narrative Identity, Aging, Elder Care, and Social Issues, Muscle Physiology and Disorders
Most-Cited Works
- → Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort(2017)187 cited
- → Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis(2016)106 cited
- → Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients(2017)63 cited
- → Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients(2020)54 cited
- → Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling(2018)53 cited
- → Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features(2018)52 cited
- → Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective(2022)16 cited
- → Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe(2024)9 cited
- → OP0221 Efficacy and Safety of Tumour Necrosis Factor-Alpha Antagonists in A Large Cohort of Juvenile Dermatomyositis Patients(2016)5 cited
- → 174 A Diagnostic and Treatment Challenge: The Prevalence and Clinical Associations of Anti-HMG-CoA Reductase Autoantibodies in a Large UK Juvenile-Onset Myositis Cohort(2016)3 cited